Crystal structure of the cystic fibrosis transmembrane conductance regulator inhibitory factor cif reveals novel active-site features of an epoxide hydrolase virulence factor

Journal of Bacteriology

Volumn 192, Issue 7, 2010, Pages 1785-1795

  Bahl, Christopher D ^a   Morisseau, Christophe ^b   Bomberger, Jennifer M ^a   Stanton, Bruce A ^a   Hammock, Bruce D ^b   O'Toole, George A ^a   Madden, Dean R ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR INHIBITORY FACTOR; EPIBROMOHYDRIN; EPOXIDE HYDROLASE; GLUTAMIC ACID; HALOACETATE DEHALOGENASE; HISTIDINE; HYDROLASE; STILBENE OXIDE; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

AMINO ACID SEQUENCE; ARTICLE; CATALYSIS; CRYSTAL STRUCTURE; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME SUBSTRATE; GENE MUTATION; HOST CELL; HUMAN; HYDROLYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; STEREOCHEMISTRY; X RAY CRYSTALLOGRAPHY;

AMINO ACID SEQUENCE; BACTERIAL PROTEINS; CATALYTIC DOMAIN; CONSERVED SEQUENCE; CRYSTALLOGRAPHY, X-RAY; EPOXIDE HYDROLASES; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY; SEQUENCE HOMOLOGY, AMINO ACID; SUBSTRATE SPECIFICITY; VIRULENCE FACTORS;

PSEUDOMONAS AERUGINOSA;

EID: 77949761912     PISSN: 00219193     EISSN: None     Source Type: Journal    
DOI: 10.1128/JB.01348-09     Document Type: Article

References (57)

1. American Thoracic Society and Infectious Diseases Society of America. 2005. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am. J. Respir. Crit. Care Med. 171:388-416.
2. Arand, M., A. Cronin, M. Adamska, and F. Oesch. 2005. Epoxide hydrolases: structure, function, mechanism, and assay. Methods Enzymol. 400:569-588.
3. Bahl, C. D., D. P. MacEachran, G. A. O'Toole, and D. R. Madden. 2010. Purification, crystallization and preliminary X-ray diffraction analysis of Cif, a virulence factor secreted by Pseudomonas aeruginosa. Acta Crystallogr. F66:26-28.
4. Bebok, Z., J. F. Collawn, J. Wakefield, W. Parker, Y. Li, K. Varga, E. J. Sorscher, and J. P. Clancy. 2005. Failure of cAMP agonists to activate rescued ΔF508 CFTR in CFBE41o- airway epithelial monolayers. J. Physiol. 569:601-615.
5. Bomberger, J. M., D. P. Maceachran, B. A. Coutermarsh, S. Ye, G. A. O'Toole, and B. A. Stanton. 2009. Long-distance delivery of bacterial virulence factors by Pseudomonas aeruginosa outer membrane vesicles. PLoS Pathog. 5:e1000382.
6. Carr, P. D., and D. L. Ollis. 2009. Alpha/beta hydrolase fold: an update. Protein Peptide Lett. 16:1137-1148.
7. Cedrone, F., T. Bhatnagar, and J. C. Baratti. 2005. Colorimetric assays for quantitative analysis and screening of epoxide hydrolase activity. Biotechnol. Lett. 27:1921-1927.
8. Chaloupková, R., J. Sykorova, Z. Prokop, A. Jesenska, M. Monincova, M. Pavlova, M. Tsuda, Y. Nagata, and J. Damborsky. 2003. Modification of activity and specificity of haloalkane dehalogenase from Sphingomonas paucimobilis UT26 by engineering of its entrance tunnel. J. Biol. Chem. 278:52622-52628.
9. Chiamvimonvat, N., C. M. Ho, H. J. Tsai, and B. D. Hammock. 2007. The soluble epoxide hydrolase as a pharmaceutical target for hypertension. J. Cardiovasc. Pharmacol. 50:225-237.
10. Chovancova, E., J. Kosinski, J. M. Bujnicki, and J. Damborsky. 2007. Phylogenetic analysis of haloalkane dehalogenases. Proteins 67:305-316.
11. Collaborative Computational Project, Number 4. 1994. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D 50:760-763.
12. Costerton, J. W., P. S. Stewart, and E. P. Greenberg. 1999. Bacterial biofilms: a common cause of persistent infections. Science 284:1318-1322.
13. Cushing, P. R., A. Fellows, D. Villone, P. Boisguerin, and D. R. Madden. 2008. The relative binding affinities of PDZ partners for CFTR: a biochemical basis for efficient endocytic recycling. Biochemistry 47:10084-10098.
14. Dam, J., and P. Schuck. 2004. Calculating sedimentation coefficient distributions by direct modeling of sedimentation velocity concentration profiles. Methods Enzymol. 384:185-212.
15. Davies, J. C., and D. Bilton. 2009. Bugs, biofilms, and resistance in cystic fibrosis. Respir. Care 54:628-640.
16. Debernard, S., C. Morisseau, T. F. Severson, L. Feng, H. Wojtasek, G. D. Prestwich, and B. D. Hammock. 1998. Expression and characterization of the recombinant juvenile hormone epoxide hydrolase (JHEH) from Manduca sexta. Insect Biochem. Mol. Biol. 28:409-419.
17. DeLano, W. L. 2008. The PyMOL molecular graphics system. DeLano Scientific LLC, Palo Alto, CA.
18. Dietze, E. C., E. Kuwano, and B. D. Hammock. 1994. Spectrophotometric substrates for cytosolic epoxide hydrolase. Anal. Biochem. 216:176-187.
19. Donnelly, C., and C. D. Murphy. 2009. Purification and properties of fluoroacetate dehalogenase from Pseudomonas fluorescens DSM 8341. Biotechnol. Lett. 31:245-250.
20. Eegriwe, E. 1932. Reaktionen und Reagenzien zum Nachweis organischer Verbindungen I. Fresenius Zeitschrift Analytische Chemie 89:121-125.
21. Emsley, P., and K. Cowtan. 2004. Coot: model-building tools for molecular graphics. Acta Crystallogr. D 60:2126-2132.
22. Geller, D. E. 2009. Aerosol antibiotics in cystic fibrosis. Respir. Care 54:658-670.
23. Gill, S. S., K. Ota, and B. D. Hammock. 1983. Radiometric assays for mammalian epoxide hydrolases and glutathione S-transferase. Anal. Biochem. 131:273-282.
24. Gribble, G. W. 1973. Fluoroacetate toxicity. J. Chem. Educ. 50:460-462.
25. Hammock, B. D., D. H. Storms, and D. F. Grant. 1997. Epoxide hydrolases, p. 283-305. In F. P. Guengerich (ed.), Comprehensive toxicology, vol. 3. Pergamon, Oxford, United Kingdom.
26. Hendlich, M., F. Rippmann, and G. Barnickel. 1997. LIGSITE: automatic and efficient detection of potential small molecule-binding sites in proteins. J. Mol. Graph Model 15:359-389.
27. Holloway, P., J. T. Trevors, and H. Lee. 1998. A colorimetric assay for detecting haloalkane dehalogenase activity. J. Microbiol. Methods 32:31-36.
28. Holm, L., S. Kaariainen, P. Rosenstrom, and A. Schenkel. 2008. Searching protein structure databases with DaliLite v. 3. Bioinformatics 24:2780-2781.
29. Jitsumori, K., R. Omi, T. Kurihara, A. Kurata, H. Mihara, I. Miyahara, K. Hirotsu, and N. Esaki. 2009. X-Ray crystallographic and mutational studies of fluoroacetate dehalogenase from Burkholderia sp. strain FA1. J. Bacteriol. 191:2630-2637.
30. Jones, A. M. 2005. Eradication therapy for early Pseudomonas aeruginosa infection in CF: many questions still unanswered. Eur. Respir. J. 26:373-375.
31. Kabsch, W. 1993. Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants. J. Appl. Crystallogr. 26:795-800.
32. Kadurugamuwa, J. L., and T. J. Beveridge. 1995. Virulence factors are released from Pseudomonas aeruginosa in association with membrane vesicles during normal growth and exposure to gentamicin: a novel mechanism of enzyme secretion. J. Bacteriol. 177:3998-4008.
33. Lacourciere, G. M., and R. N. Armstrong. 1994. Microsomal and soluble epoxide hydrolases are members of the same family of C-X bond hydrolase enzymes. Chem. Res. Toxicol. 7:121-124.
34. Laue, T. M., B. D. Shah, T. M. Ridgeway, and S. L. Pelletier. 1992. Computer-aided interpretation of analytical sedimentation data for proteins, p. 90-125. In S. E. Harding, A. J. Rowe, and J. C. Horton (ed.), Analytical ultracentrifugation in biochemistry and polymer sciences. Royal Society for Chemistry, Cambridge, United Kingdom.
35. Leonard, G. A., G. Sainz, M. M. de Backer, and S. McSweeney. 2005. Automatic structure determination based on the single-wavelength anomalous diffraction technique away from an absorption edge. Acta Crystallogr. D 61:388-396.
36. MacEachran, D. P., B. A. Stanton, and G. A. O'Toole. 2008. Cif is negatively regulated by the TetR family repressor CifR. Infect. Immun. 76:3197-3206.
37. MacEachran, D. P., S. Ye, J. M. Bomberger, D. A. Hogan, A. Swiatecka-Urban, B. A. Stanton, and G. A. O'Toole. 2007. The Pseudomonas aeruginosa secreted protein PA2934 decreases apical membrane expression of the cystic fibrosis transmembrane conductance regulator. Infect. Immun. 75:3902-3912.
38. Morisseau, C., and B. D. Hammock. 2005. Epoxide hydrolases: mechanisms, inhibitor designs, and biological roles. Annu. Rev. Pharmacol. Toxicol. 45: 311-333.
39. Morisseau, C., and B. D. Hammock. 2008. Gerry Brooks and epoxide hydrolases: four decades to a pharmaceutical. Pest Manag. Sci. 64:594-609.
40. Morisseau, C., and B. D. Hammock. 2007. Measurement of soluble epoxide hydrolase (sEH) activity. Curr. Protoc. Toxicol. 33:4.23.1-4.23. 18.
41. Moyer, B. D., J. Loffing, E. M. Schwiebert, D. Loffing-Cueni, P. A. Halpin, K. H. Karlson, I. I. Ismailov, W. B. Guggino, G. M. Langford, and B. A. Stanton. 1998. Membrane trafficking of the cystic fibrosis gene product, cystic fibrosis transmembrane conductance regulator, tagged with green fluorescent protein in Madin-Darby canine kidney cells. J. Biol. Chem. 273: 21759-21768.
42. Murphy, T. F., A. L. Brauer, K. Eschberger, P. Lobbins, L. Grove, X. Cai, and S. Sethi. 2008. Pseudomonas aeruginosa in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 177:853-860.
43. Nardini, M., I. S. Ridder, H. J. Rozeboom, K. H. Kalk, R. Rink, D. B. Janssen, and B. W. Dijkstra. 1999. The x-ray structure of epoxide hydrolase from Agrobacterium radiobacter AD1. An enzyme to detoxify harmful epoxides. J. Biol. Chem. 274:14579-14586.
44. Ollis, D. L., E. Cheah, M. Cygler, B. Dijkstra, F. Frolow, S. M. Franken, M. Harel, S. J. Remington, I. Silman, J. Schrag, J. L. Sussman, K. H. G. Verschueren, and A. Goldman. 1992. The α/β hydrolase fold. Protein Eng. 5:197-211.
45. Petrek, M., M. Otyepka, P. Banas, P. Kosinova, J. Koca, and J. Damborsky. 2006. CAVER: a new tool to explore routes from protein clefts, pockets and cavities. BMC Bioinformatics 7:316.
46. Qian, Z., C. J. Fields, Y. Yu, and S. Lutz. 2007. Recent progress in engineering α/β hydrolase-fold family members. Biotechnol. J. 2:192-200.
47. Stover, C. K., X. Q. Pham, A. L. Erwin, S. D. Mizoguchi, P. Warrener, M. J. Hickey, F. S. Brinkman, W. O. Hufnagle, D. J. Kowalik, M. Lagrou, R. L. Garber, L. Goltry, E. Tolentino, S. Westbrock-Wadman, Y. Yuan, L. L. Brody, S. N. Coulter, K. R. Folger, A. Kas, K. Larbig, R. Lim, K. Smith, D. Spencer, G. K. Wong, Z. Wu, I. T. Paulsen, J. Reizer, M. H. Saier, R. E. Hancock, S. Lory, and M. V. Olson. 2000. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 406:959-964.
48. Swiatecka-Urban, A., M. Duhaime, B. Coutermarsh, K. H. Karlson, J. Collawn, M. Milewski, G. R. Cutting, W. B. Guggino, G. Langford, and B. A. Stanton. 2002. PDZ domain interaction controls the endocytic recycling of the cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 277:40099-40105.
49. Swiatecka-Urban, A., S. Moreau-Marquis, D. P. Maceachran, J. P. Connolly, C. R. Stanton, J. R. Su, R. Barnaby, G. A. O'Toole, and B. A. Stanton. 2006. Pseudomonas aeruginosa inhibits endocytic recycling of CFTR in polarized human airway epithelial cells. Am. J. Physiol. Cell Physiol. 290:C862-C872.
50. Terwilliger, T. C., R. W. Grosse-Kunstleve, P. V. Afonine, N. W. Moriarty, P. D. Adams, R. J. Read, P. H. Zwart, and L. W. Hung. 2008. Iterative-build OMIT maps: map improvement by iterative model building and refinement without model bias. Acta Crystallogr D. 64:515-524.
51. Thompson, J. D., D. G. Higgins, and T. J. Gibson. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:4673-4680.
52. van Loo, B., J. Kingma, M. Arand, M. G. Wubbolts, and D. B. Janssen. 2006. Diversity and biocatalytic potential of epoxide hydrolases identified by genome analysis. Appl. Environ. Microbiol. 72:2905-2917.
53. Wolff, W. 1893. Ueber ein dinaphtoxanthen (methylendinaphtylenoxyd). Berichte Deutschen Chemischen Gesellschaft 26:83-86.
54. Wood, D. M., and A. R. Smyth. 2006. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis. Cochrane Database Syst. Rev. 2006:CD004197.
55. Yamada, T., C. Morisseau, J. E. Maxwell, M. A. Argiriadi, D. W. Christianson, and B. D. Hammock. 2000. Biochemical evidence for the involvement of tyrosine in epoxide activation during the catalytic cycle of epoxide hydrolase. J. Biol. Chem. 275:23082-23088.
56. Ye, S., D. P. MacEachran, J. W. Hamilton, G. A. O'Toole, and B. A. Stanton. 2008. Chemotoxicity of doxorubicin and surface expression of P-glycoprotein (MDR1) is regulated by the Pseudomonas aeruginosa toxin Cif. Am. J. Physiol. Cell Physiol. 295:C807-C818.
57. Zou, J., B. M. Hallberg, T. Bergfors, F. Oesch, M. Arand, S. L. Mowbray, and T. A. Jones. 2000. Structure of Aspergillus niger epoxide hydrolase at 1.8 Å resolution: implications for the structure and function of the mammalian microsomal class of epoxide hydrolases. Structure 8:111-122.